Literature DB >> 35967160

Second Case of Tumors Associated With Heterozygous NTHL1 Variant.

Danyon J Anderson1, Trenton Reinicke2, Andrew W Boyle3, Mokshal H Porwal1, Allan H Friedman4.   

Abstract

Homozygous mutations to NTHL1 are known to increase cancer risk, particularly in the colon and breast. NTHL1 tumor syndrome (NTS) is an autosomal recessive genetic condition. Little is known about the cancer risk in patients who have heterozygous NTHL1 mutations. We previously published a case of benign tumors associated with a heterozygous NTHL1 mutation. In this second case, we present a patient with a heterozygous NTHL1 mutation who developed a gastrointestinal stromal tumor, pilocytic astrocytoma, tall cell papillary thyroid cancer, invasive ductal papilloma, spinal nerve sheath tumors, and spinal hemangiomas. Here, we show that heterozygous NTHL1 mutations may increase cancer risk and may even manifest similarly to NTS.
Copyright © 2022, Anderson et al.

Entities:  

Keywords:  gastrointestinal stromal tumor (gist); heterozygous; invasive ductal cell carcinoma; meningioma; nthl1; nthl1 tumor syndrome; papillary carcinoma of thyroid; pilocytic astrocytoma

Year:  2022        PMID: 35967160      PMCID: PMC9364427          DOI: 10.7759/cureus.26734

Source DB:  PubMed          Journal:  Cureus        ISSN: 2168-8184


  13 in total

1.  A germline homozygous mutation in the base-excision repair gene NTHL1 causes adenomatous polyposis and colorectal cancer.

Authors:  Robbert D A Weren; Marjolijn J L Ligtenberg; C Marleen Kets; Richarda M de Voer; Eugène T P Verwiel; Liesbeth Spruijt; Wendy A G van Zelst-Stams; Marjolijn C Jongmans; Christian Gilissen; Jayne Y Hehir-Kwa; Alexander Hoischen; Jay Shendure; Evan A Boyle; Eveline J Kamping; Iris D Nagtegaal; Bastiaan B J Tops; Fokko M Nagengast; Ad Geurts van Kessel; J Han J M van Krieken; Roland P Kuiper; Nicoline Hoogerbrugge
Journal:  Nat Genet       Date:  2015-05-04       Impact factor: 38.330

Review 2.  Pediatric Cancer Predisposition Imaging: Focus on Whole-Body MRI.

Authors:  Mary-Louise C Greer; Stephan D Voss; Lisa J States
Journal:  Clin Cancer Res       Date:  2017-06-01       Impact factor: 12.531

3.  Mutational Signature Analysis Reveals NTHL1 Deficiency to Cause a Multi-tumor Phenotype.

Authors:  Judith E Grolleman; Richarda M de Voer; Fadwa A Elsayed; Maartje Nielsen; Robbert D A Weren; Claire Palles; Marjolijn J L Ligtenberg; Janet R Vos; Sanne W Ten Broeke; Noel F C C de Miranda; Renske A Kuiper; Eveline J Kamping; Erik A M Jansen; M Elisa Vink-Börger; Isabell Popp; Alois Lang; Isabel Spier; Robert Hüneburg; Paul A James; Na Li; Marija Staninova; Helen Lindsay; David Cockburn; Olivera Spasic-Boskovic; Mark Clendenning; Kevin Sweet; Gabriel Capellá; Wenche Sjursen; Hildegunn Høberg-Vetti; Marjolijn C Jongmans; Kornelia Neveling; Ad Geurts van Kessel; Hans Morreau; Frederik J Hes; Rolf H Sijmons; Hans K Schackert; Clara Ruiz-Ponte; Dagmara Dymerska; Jan Lubinski; Barbara Rivera; William D Foulkes; Ian P Tomlinson; Laura Valle; Daniel D Buchanan; Sue Kenwrick; Julian Adlard; Aleksandar J Dimovski; Ian G Campbell; Stefan Aretz; Detlev Schindler; Tom van Wezel; Nicoline Hoogerbrugge; Roland P Kuiper
Journal:  Cancer Cell       Date:  2019-02-11       Impact factor: 31.743

Review 4.  Update on genetic predisposition to colorectal cancer and polyposis.

Authors:  Laura Valle; Richarda M de Voer; Yael Goldberg; Wenche Sjursen; Asta Försti; Clara Ruiz-Ponte; Trinidad Caldés; Pilar Garré; Maren F Olsen; Margareta Nordling; Sergi Castellvi-Bel; Kari Hemminki
Journal:  Mol Aspects Med       Date:  2019-03-18

Review 5.  Intestinal and extraintestinal neoplasms in patients with NTHL1 tumor syndrome: a systematic review.

Authors:  S H Beck; A M Jelsig; H M Yassin; L J Lindberg; K A W Wadt; J G Karstensen
Journal:  Fam Cancer       Date:  2022-03-16       Impact factor: 2.375

Review 6.  NTHL1 in genomic integrity, aging and cancer.

Authors:  Lipsa Das; Victoria G Quintana; Joann B Sweasy
Journal:  DNA Repair (Amst)       Date:  2020-09

7.  NTHL1 biallelic mutations seldom cause colorectal cancer, serrated polyposis or a multi-tumor phenotype, in absence of colorectal adenomas.

Authors:  Sami Belhadj; Isabel Quintana; Pilar Mur; Pau M Munoz-Torres; M Henar Alonso; Matilde Navarro; Mariona Terradas; Virginia Piñol; Joan Brunet; Victor Moreno; Conxi Lázaro; Gabriel Capellá; Laura Valle
Journal:  Sci Rep       Date:  2019-06-21       Impact factor: 4.379

8.  Expression of a germline variant in the N-terminal domain of the human DNA glycosylase NTHL1 induces cellular transformation without impairing enzymatic function or substrate specificity.

Authors:  Carolyn G Marsden; Pawel Jaruga; Erdem Coskun; Robyn L Maher; David S Pederson; Miral Dizdaroglu; Joann B Sweasy
Journal:  Oncotarget       Date:  2020-06-16

9.  Monoallelic NTHL1 Loss-of-Function Variants and Risk of Polyposis and Colorectal Cancer.

Authors:  Fadwa A Elsayed; Judith E Grolleman; Abiramy Ragunathan; Daniel D Buchanan; Tom van Wezel; Richarda M de Voer
Journal:  Gastroenterology       Date:  2020-08-26       Impact factor: 22.682

10.  Benign Tumors Associated With Heterozygous NTHL1 Variant.

Authors:  Danyon J Anderson; Andrew Boyle; Trenton Reinicke; Bison Woods; Patrick Hsieh
Journal:  Cureus       Date:  2021-07-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.